CTRI/2020/08/026992招募中2 期
Efficacy of weekly paclitaxel in combination with daily oral sodium valproate in relapsed and refractory lymphoma patients- A phase II study
Jawaharlal Institute Post Graduate Medical Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Adult patients with relapsed and refractorylymphoma unfit for aggresive chemotherapy
- •ECOG PS less than or equal to 2
- •Patients should have following lab parameters fulfilled within 14 days of enrollment
- •Absolute neutrophil count >=1000/L
- •Platelet count >= 75000/L
- •Adequate hepatic function defined as Total Bilirubin < 5 times upper limit of normal (ULN), Alaninine transaminase(ALT)/Aspartate transaminase(AST) <3 x ULN
- •Serum creatinine < 2.0 mg/dl
排除标准
- •i.Patient unwilling for study
- •ii.Pregnant and breastfeeding women
- •iii.Patients on oral sodium valproate for any other indication.
- •iv.Patients with history of hypersensitivity to valproate or paclitaxel.
- •v.Patients with peripheral neuropathy of grade 2 or more as per NCI CTCAE Ver 5.1
- •vi.Patients of HIV/Hepatitis B/Hepatitis C infection.
- •vii.Patients with CNS disease as part of NHL/HL and lymphoblastic lymphoma(LBL)
研究者
相似试验
已完成
2 期
Comparison of efficacy of Paclitaxel with Cisplatin when given weekly along with radiation in patients suffering from Head and Neck cancers.CTRI/2017/09/009864Jawaharlal Institute of Post Graduate Medical Education and Research54
尚未招募
2 期
ow dose cancer drugs for advanced stomach cancerCTRI/2022/11/047033JIPMER PONDICHERRY
已完成
2 期
Assessment of efficacy of weekly paclitaxel chemotherapy in ovarian cancersAdvanced Ovarian Cancer.Malignant neoplasm of ovaryIRCT2017050333789N1Taleghani Hospital- Shahid Beheshti University of Medical Sciences14
招募中
2 期
Phase II study of a Combination of Paclitaxel and 5'-DFUR in Patients with S-1 Failure Unresectable or Recurrent Gastric CancerAdvanced or recurrent gastric cancer previously treated with S-1JPRN-UMIN000008632Department of Digestive Surgery and Surgical Oncology, Yamaguchi University Graduate School of Medicine35
进行中（未招募）
不适用
Weekly maintainance therapy with Paclitaxel vs control arm after first line chemotherapy in patients with metastatic breast carcinoma. Phase III multicentric clinical trial.breast cancerEUCTR2004-004031-59-ITAZIENDA OSPEDALIERA POLICLINICO DI MODENA